MissionoftheSETGyCThe Spanish Society for Gene and Cell Therapy (SETGyC) is a platform that aims to promote andsupport fundamental, translational and clinical research in these areas, as well as collaboration withinstitutions, biotechnological and pharmaceutical companies for development of new therapies. Thecomplexity of these studies often requires a multidisciplinary approach and our Society is an idealforum to find colleagues with whom to share knowledge and procedures for the development of new,more effective and safe therapies as well as good practice in gene and cell therapy products and inthe clinical application of these products.

Many of the teams that have implemented clinical trials on advanced therapies are members of theSETGyC, which aims to facilitate the translation of fundamental research to medical applicationscomplying with European regulations for cell therapy and gene therapy, to advise on these aspectsand to defend the good practice in cell production and in clinical application of cellular products.

Our congress is the opportunity for all the people involved in the Society (researchers, clinicians,industry and government representatives) to meet. For students in particular, this is a great chance topresent their work, exchange knowledge and form collaborations, all of which are very important fortheir training. In the last few years, Society meetings have taken place in Madrid (2007), Granada(2009), Zaragoza (2011), Madrid (2013), the latter in partnership with the annual meeting ofthe European Society of Gene and Cell Therapy (ESGCT) and San Sebastian (2015)

Biennial Congress

• To boost the profile of gene and cell therapy inSpain and internationally• To facilitate communication and exchange ofexpertise and resources between professionals• To provide advice and advocacy in all themesrelating to new and existing gene and celltherapies

• Spain is one of the leading countries in Europewith regard to the number of sponsors ofadvanced therapy medicinal products (ATMPs),which are mainly not-for-profit institutions. It isalso a leader in the number of ATMPs undergoingclinical development programs.

Source:Maciulaitis etal.(2012).MolecularTherapy;20,479–482

ObjectivesoftheSETGyC

SituationinSpain

Through its activities, the SETGyC hopes to support fundamental and translationalresearch aimed at the advancement of gene and cell therapy in Spain by promotingthe incorporation of the latest international developments in the field.

PlatinumPartners 7500EUROngoing Benefits:•Logoonhighestvisibilitytieronwebsitebanner&sponsorpage•Quarterlyemailalertstomailinglist(1000recipients)•2societymemberships,whichgiveaccesstothemembersonlyareaofwebsite.CongressBenefits:•Exhibitionspace(ifrequired)•Toptiervisibilityoncongressadvertisingmaterials•1fullpagecolouradvertincongressprogrammeorabstractbook•Solesponsorshipof1plenarysession•Distributionofflyersor1advertisingiteme.g.pens,mousemats,wifi tokenindelegatebags•2freeregistrationsand2seatsatsocialfunctions

GoldPartners 5000EUROngoing Benefits:•Logoonsecondvisibilitytieronwebsitebanner&sponsorpage• Bi-annualemailalertstomailinglist(1000recipients)•1societymembershipsgivingaccesstothemembersonlyareaofwebsiteCongressBenefits:•Exhibitionspace(ifrequested)•Secondtiervisibilityoncongressadvertisingmaterials•1halfpagecolouradvertincongressprogrammeorabstractbook•Sharedsponsorshipof1plenaryscientificsession•Distributionofyourflyersor1advertisinge.g.pens,mousemats,wifi tokenindelegatebags•2freeregistrationsand2seatsatsocialfunctions

Fees

Fees

SilverPartner 3000EUROngoing Benefits:•Logoonthirdvisibilitytieronwebsitebanner&sponsorpage•1emailalerttomailinglist(1000recipients)

CongressBenefits:•Exhibitionspace(ifrequired)•Thirdtiervisibilityoncongressadvertisingmaterials•Sponsorshipofasharedparallelsession•Distributionofyourflyersindelegatebags•2freeregistrations

Exhibitor 1500EUR•Exhibitionspace3x3metersincludingtable,twochairs,wifi andpower•2exhibitorpassesperstandperday,whichgiveaccesstolunchandrefreshmentsduringthecongress

Biennial Meeting of the SETGyC, Mallorca

WEDNESDAY 14 MARCH 2018 09:00-10:30

Educational 1a: Viral Vectors

Chair: Juan Carlos Ramirez, ViveBiotech. San Sebastián.

Juan Carlos Ramírez. ViveBiotech. Lentiviral Vectors. Eduard Ayuso. Univ. Nantes. AAV Vectors. Ruben Hernandez Alcoceba. CIMA. Pamplona. Adenoviral vectors: evolution and current perspectives. ROUND TABLE (15min)

Educational 1b: Cellular Therapy: TERCEL

Sponsor: TERCEL

Chair: Javier García Sancho, Univ. Valladolid

Javier García Sancho.Treatment of osteoarticular diseases with mesenchymal stromal cells. Ander Izeta. Insituto Biodonostia. San Sebastián. 3rd speaker (To be announced). ROUND TABLE (15 min)

10:30-11:00 COFFEE BREAK

11:00-12:30

Educational 2a: Gene editing tools

Chair: Luis Montoliú, CNB.

Luis Montoliu CNB-CSIC and CIBERER-ISCIII, Madrid. “Generation of new animal models of rare diseases using CRISPR tools”. Raúl Torres. CNIO. Madrid. Jaime Carvajal Centro Andaluz de Biología del Desarrollo. CSIC. Sevilla “Skeletal muscle: CRISPR/Cas9 approaches to study embryonic development and human disease."

ROUND TABLE (15 min)

Educational 2b: Disease modelling using iPSC

Chair: Angel Raya, CMRB.

Xonia Carvajal-Vergara. CIMA Pamplona. Felipe Serrano 3rd speaker (TBA).

ROUND TABLE (15 min)

12:30-14.00 LUNCH

Biennial Meeting of the SETGyC, Mallorca

15:15-16:30

Plenary Session 1 Chair: Guillermo Güenechea, CIEMAT.

Juan Bueren. CIEMAT. Madrid. “Hematopoietic Gene Therapy in Fanconi Anemia Patients.”

Isabel Fariñas. Univ. Valencia. “Stem cell niche biology in the adult brain.”

16.30-17:00 COFFEE BREAK

17:00-18:30 Parallel 1a: Regulatory and Manufacturing Chair: Sol Ruíz. AEMPS. Madrid.

Sol Ruiz. “Regulatory aspects of advanced therapies”. Julie Kerby. Cell and Gene Therapy Catapult. UK. “Addressing Industrialisation and Manufacturing Hurdles”

Selected talks (3 selected abstracts).

Parallel 1b: Organoids and Gene Transfer Models Chair: Meritxel Huch. Wellcome Trust/Cancer Research UK Gurdon Institute.

University of Cambridge. UK.

Arne Fleischer. Caubet-Cimera Foundation. Mallorca.

Meritxell Hugh. “Liver organoids for the study of liver biology and

disease”.

Selected talks (3 selected abstracts).

18:30-20:00 Parallel 2a: Gene Editing

Chair: José Carlos Segovia, CIEMAT/CIBERER/IIS-FJD

Paula Río. CIEMAT. Madrid. “Edición génica en células hematopoyéticas de pacientes con anemia de Fanconi.” Francisco Martín. Genyo. Granada.

Selected talks (3 selected abstracts).

Parallel 2b: Pluripotent stem cells and cell reprogramming Chair: Angel Raya, CMRB. Barcelona.

Angel Raya. Regenerative Medicine Center. Barcelona. Pablo Menendez. Josep Carreras Leukaemia Research Institute.University of Barcelona. “iPSC-based modeling of human genetic and malignant diseases”

Selected talks (3 selected abstracts).

14:00-15:15

Inaugural Session Chair: Ramón Alemany ( SETGYC Society Update )

Adrian Thrasher. University College London

“Gene therapy as a standard of care.” Ernest Arenas, Karolinska Institutet, Stockholm, Sweden.

“Regenerative Therapies for Parkinson’s disease”

Biennial Meeting of the SETGyC, Mallorca

20:00-21:30 WELCOME AND POSTERS

09:00-10:30

Plenary Session 2

Chair: José Luis Labandeira, CIMUS-IDIS, U de Santiago de Compostela Fátima Bosch. Autonomous University of Barcelona.

Gene Therapy of mucopolysaccharidosis. Simón Méndez Ferrer Hospital Universitario Virgen del Rocío. Sevilla

10:30-11:00

Elevator Pitch Chair: Eusebio Gainza, Praxis.

6 Selected Industry-oriented Talks. 11:00-11:30 COFFEE BREAK

11:30-13:00 Parallel 3a: Cell and gene therapy of metabolic diseases Chair: Fatima Bosch, UAB.

Gloria González-Aseguinolaza. CIMA.Pamplona. “Gene therapy

for hepatic metabolic inherited disorders using AAV vectors”. 2nd speaker TBC.

Selected talks (3 selected abstracts).

Parallel 3b:Cell and gene therapy cardiovascular diseases Chair: Pilar Sepúlveda, IIS-La Fe

Antonio Bernad. CNB. Madrid. "Bmi1+ adult cardiac progenitors are

critical for in vivo heart function after acute myocardial infarct" Pilar Sepúlveda. Instituto Sanitario La Fe. Valencia. “Genetic

Modification of Mesenchymal cells to increase their therapeutic effect:

role of exosomes.” Selected talks (3 selected abstracts).

13:00-14:30 LUNCH

14:30-16:00 Parallel 4a: Cell and gene therapy of blood disorders Chair: Juan A. Bueren, CIEMAT.

José Carlos Segovia. CIEMAT. Madrid. “Gene therapy of

pyruvate kinase deficiency.” José Antonio Perez Simón. Instituto de Biomedicina de Sevilla.

Selected talks (3 selected abstracts).

Parallel 4b: Cell and gene therapy of skin and muscle Chair: Ander Izeta, Biodonostia.

Pura Muñoz. UPF–ICREA Barcelona/CNIC Madrid.

“Understanding muscle stem cell regenerative decline with aging.”

Fernando Larcher. CIEMAT. Madrid “Gene therapy of skin diseases.”

Selected talks (3 selected abstracts)

16:00-16:30 COFFEE BREAK

THURSDAY 15 MARCH 2018

Biennial Meeting of the SETGyC, Mallorca

16:30-18:00 Parallel 5a: Cell and gene therapy of neurodegenerative diseases

Chair: Juan José Toledo Aral. Juan José Toledo Aral. IBiS - Instituto de Biomedicina de Sevilla. “Antiparkinsonian Cell Therapy using Carotid Body”. Nathalie Cartier. INSERM. Paris. “Gene therapy for Huntington’s disease”.

Selected talks (3 selected abstracts).

Parallel 5b: Cell and gene immunotherapy Chair: Daniel Bachiller, Fundación Caubet-Cimera

Daniel Bachiller. “Genome Editing Tools for the treatment of AIDS”. Manel Juan. Hosp. Clínico Barcelona, IDIBAPS. “CART immunotherapy; from our experience to the future.”

Selected talks (3 selected abstracts).

18:00-19:30 POSTER SESSION

19:30-20:00 SETGYC GENERAL ASSEMBLY

21:00 GALA DINNER

09:00-10:30 Parallel 6a: Cell and Gene therapy of cancer Chair: Manuel Ramírez Orellana

Ramon Alemany. Catalan Institute of Oncology. Barcelona. “Oncolytic Adenoviruses”. Alena Gros. Vall Hebron Institute of Oncology. Barcelona. “TIL therapy of cancer”.

Selected talks (3 selected abstracts).

Parallel 6b: Rare diseases: leading gene and cell therapy Chair: Gloria González Aseguinolaza, CIMA

Antonio Fontanellas. CIMA-University of Navarra. "Efficacy of systemic messenger RNA therapy in experimental models of acute porphyria". Salvador Martínez. TBC.

Selected talks (3 selected abstracts). 10:30-11:00 Coffee Break 11:00-12:30

Plenary Session 3 Chair: Paula Rio, CIEMAT/CIBERER/IIS-FJD

Pietro Genovese San Raffaele Telethon Institute for Gene Therapy. Milan. Italy.

“Exploiting the Therapeutic Potential of Hematopoietic Stem Cells Gene Editing for the Treatment of Inherited Diseases”

Francisco Sánchez Madrid CNIC e Instituto de Investigación Sanitaria La Princesa, Madrid.

12:30-13:45 Award Ceremony and Closing Lecture Chairs: Ramon Aleman and Angel Raya.

Closing Lecture: Damián Garcia Olmo. Hospital Universitario Fundación Jiménez Díaz. Madrid.

"A Long and Winding Road to make from Cells a Surgical Tool"

FRIDAY 16 MARCH 2018

Venue

HotelBarcelo Illetas AlbatrosSeasidelocationrightnexttoPalmadeMallorca,hotelandcongressvenueinonelocationforaretreattypecongress

Venue